Title: Staphylococcus saprophyticus: Which beta-lactam? - ScienceDirect
Headings: Staphylococcus saprophyticus
: Which beta-lactam?

International Journal of Infectious Diseases
Short Communication
Staphylococcus saprophyticus: Which beta-lactam?
Highlights
Abstract
Background
Methods
Results
Conclusions
Keywords
Introduction
Methods
Results
Discussion
Conflict of interest/funding
References

Content: Download : Download high-res image (208KB)
Download : Download full-size image
Figure 2. Distribution of Minimal Inhibitory Concentrations (MIC) of ceftriaxone and amoxicillin-clavulanic acid of Staphylococcus saprophyticus and Staphylococcus aureus strains tested by broth microdilution method. S. saprophyticus strains are represented by the black bars, and S. aureus by the white ones. Discussion
In the literature, the prevalence of MSSS in UTI varies from 3% to 42%, depending on factors such as patient age ( Hur et al., 2016, Lo et al., 2015 ). Complications of UTIs due to MSSS such as pyelonephritis, nephrolithiasis, and in the case of male patients, urethritis, epididymitis, and prostatitis, are uncommonly reported ( Chen, 2014, Hovelius and Mårdh, 1984, Raz et al., 2005 ).